Summit to focus on government dengue collaboration
Health & Leisure
Tuesday, 12 January 2016
On the heels of Asia's first dengue vaccine approval in the Philippines, the inaugural Asian Dengue Summit in Bangkok on January 13 will make a rallying call to governments and health authorities in Asia to collaborate and integrate regional efforts to wage war on dengue and 'open a new chapter' in dengue prevention and control.
Making this collective call is the Asian Dengue Vaccination Advocacy (ADVA), a scientific working group that is staging a two-day summit in partnership with the Dengue Vaccine Initiative (DVI).
The ADVA coalition will leverage its expertise to help governments in the region curb the growing dengue burden. Leading regional clinicians, researchers, public health leaders, government officials and policymakers will attend the summit to share and exchange their scientific findings and dengue prevention and treatment experiences from their countries.
In the past 50 years, dengue has become endemic in 128 countries where about four billion people live. This marks a 30-fold increase in dengue incidence. Not surprisingly, dengue is feared as one of the most severe mosquito-borne viral diseases in the world.
Over 740 people are infected by dengue per minute, globally.
Asia has the highest dengue burden globally, with an estimated 67 million people contracting the disease each year.
Endemic countries in Asia spend nearly US$6.5 billion annually in both direct medical and indirect costs due to dengue.
Summit to focus on government dengue collaboration
Health & Leisure
Tuesday, 12 January 2016
On the heels of Asia's first dengue vaccine approval in the Philippines, the inaugural Asian Dengue Summit in Bangkok on January 13 will make a rallying call to governments and health authorities in Asia to collaborate and integrate regional efforts to wage war on dengue and 'open a new chapter' in dengue prevention and control.
Making this collective call is the Asian Dengue Vaccination Advocacy (ADVA), a scientific working group that is staging a two-day summit in partnership with the Dengue Vaccine Initiative (DVI).
The ADVA coalition will leverage its expertise to help governments in the region curb the growing dengue burden. Leading regional clinicians, researchers, public health leaders, government officials and policymakers will attend the summit to share and exchange their scientific findings and dengue prevention and treatment experiences from their countries.
In the past 50 years, dengue has become endemic in 128 countries where about four billion people live. This marks a 30-fold increase in dengue incidence. Not surprisingly, dengue is feared as one of the most severe mosquito-borne viral diseases in the world.
Over 740 people are infected by dengue per minute, globally.
Asia has the highest dengue burden globally, with an estimated 67 million people contracting the disease each year.
Endemic countries in Asia spend nearly US$6.5 billion annually in both direct medical and indirect costs due to dengue.
